IN149490B - - Google Patents

Info

Publication number
IN149490B
IN149490B IN920/CAL/78A IN920CA1978A IN149490B IN 149490 B IN149490 B IN 149490B IN 920CA1978 A IN920CA1978 A IN 920CA1978A IN 149490 B IN149490 B IN 149490B
Authority
IN
India
Application number
IN920/CAL/78A
Inventor
P Lawrie
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Inc filed Critical Ethicon Inc
Publication of IN149490B publication Critical patent/IN149490B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043—Mixtures of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005—The prosthesis being constructed from a particular material
    • A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
    • A61F2310/00377—Fibrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Materials For Medical Uses (AREA)
IN920/CAL/78A 1977-12-05 1978-08-21 IN149490B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB50503/77A GB1584080A (en) 1977-12-05 1977-12-05 Absorbable hemostatic composition

Publications (1)

Publication Number Publication Date
IN149490B true IN149490B (en) 1981-12-26

Family

ID=10456141

Family Applications (1)

Application Number Title Priority Date Filing Date
IN920/CAL/78A IN149490B (en) 1977-12-05 1978-08-21

Country Status (10)

Country Link
CA (1) CA1119515A (en)
DE (1) DE2852319A1 (en)
FR (1) FR2410477A1 (en)
GB (1) GB1584080A (en)
HK (1) HK34681A (en)
HU (1) HU179969B (en)
IE (1) IE47606B1 (en)
IL (1) IL56110A (en)
IN (1) IN149490B (en)
MY (1) MY8200056A (en)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981000516A1 (en) * 1979-08-31 1981-03-05 Merck Patent Gmbh Gel containing fibrine and antibiotic for treating infected bones and preparation process thereof
EP0030583B1 (en) * 1979-12-18 1984-06-13 Oscobal Ag Bone replacement material and process for producing a bone replacement material
DE3014123C2 (en) * 1980-04-12 1982-03-18 B. Braun Melsungen Ag, 3508 Melsungen Process for the production of scleroprotein transplants with increased biological stability
EP0086627B1 (en) * 1982-02-12 1985-08-28 Unitika Ltd. Anti-cancer device
USRE32208E (en) * 1982-11-16 1986-07-15 Ethicon, Inc. Absorbable hemostatic composition
US4440789A (en) * 1982-11-16 1984-04-03 Ethicon, Inc. Synthetic absorbable hemostatic composition
US4439420A (en) * 1982-11-16 1984-03-27 Ethicon, Inc. Absorbable hemostatic composition
US4443430A (en) * 1982-11-16 1984-04-17 Ethicon, Inc. Synthetic absorbable hemostatic agent
DE3374659D1 (en) * 1983-02-03 1988-01-07 Ethicon Inc Paste for hemostasis and for temporary relief of defects in the traumatism of bones
EP0166263A1 (en) * 1984-05-31 1986-01-02 Green Cross Corporation Filler composition for filling in defect or hollow portion of bone and kit or set for the preparation of the filler composition
JPS61122222A (en) * 1984-11-19 1986-06-10 Koken:Kk Hemostatic agent composed of collagen or gelatin and protamine
US4891359A (en) * 1988-12-08 1990-01-02 Johnson & Johnson Patient Care, Inc. Hemostatic collagen paste composition
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6197325B1 (en) 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6117425A (en) * 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US6559119B1 (en) 1990-11-27 2003-05-06 Loyola University Of Chicago Method of preparing a tissue sealant-treated biomedical material
US7208179B1 (en) 1990-11-27 2007-04-24 The American National Red Cross Methods for treating disease and forming a supplemented fibrin matrix
AU2572692A (en) 1991-09-09 1993-04-05 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods and devices for treating hemophilia and aids
GB9211432D0 (en) * 1992-05-29 1992-07-15 Jevco Ltd Absorbable bone sealant
US5696101A (en) * 1996-04-16 1997-12-09 Eastman Chemical Company Oxidized cellulose and vitamin E blend for topical hemostatic applications
US6117444A (en) * 1997-04-10 2000-09-12 Brigham & Women's Hospital Polyethylene glycol/microfibrillar collagen composite serves as a resorbable hemostatic agent
US6762336B1 (en) 1998-01-19 2004-07-13 The American National Red Cross Hemostatic sandwich bandage
DE19858891A1 (en) * 1998-12-19 2000-06-21 Merck Patent Gmbh Improved bone seals
US7923431B2 (en) 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
AU2003270401B2 (en) 2002-09-10 2008-03-13 American National Red Cross Hemostatic dressing
MXPA05006193A (en) 2002-12-11 2005-12-05 Ferrosan As Gelatine-based materials as swabs.
US7955616B2 (en) 2003-09-23 2011-06-07 Orthocon, Inc. Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
US7989000B2 (en) 2003-09-23 2011-08-02 Orthocon, Inc. Absorbable putty-like implants and methods for their use for mechanical hemostasis of bone and for the treatment of osseous defects
NZ545521A (en) 2003-09-23 2010-02-26 Orthocon Inc Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
DE10357460A1 (en) * 2003-12-04 2005-07-07 Friedrich-Baur-Gmbh Bioresorbable material
CN1921896B (en) * 2004-01-30 2010-11-24 弗罗桑公司 Hemostatic sprays and compositions
RU2369408C2 (en) 2004-07-09 2009-10-10 Ферросан А/С Hemostatic composition comprising hyaluronic acid
US8603528B2 (en) 2004-09-16 2013-12-10 Abyrx, Inc. Compositions and method for the reduction of post-operative pain
US8506646B2 (en) 2005-04-29 2013-08-13 Warsaw Orthopedic, Inc. Multi-purpose medical implant devices
US8092464B2 (en) 2005-04-30 2012-01-10 Warsaw Orthopedic, Inc. Syringe devices and methods useful for delivering osteogenic material
US20080033333A1 (en) 2006-08-04 2008-02-07 Macphee Martin Solid dressing for treating wounded tissue
US20090075891A1 (en) 2007-08-06 2009-03-19 Macphee Martin Methods and dressings for sealing internal injuries
EP2237806A2 (en) * 2007-12-26 2010-10-13 Metamorefix Pulverrized fibrin clots and pharmaceutical compositions containing them
EP2259803B2 (en) 2008-02-29 2019-03-13 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
DE202010009512U1 (en) 2010-05-28 2011-01-13 Hfp Ingredients B.V. collagen powder
RU2657955C2 (en) 2012-03-06 2018-06-18 Ферросан Медикал Дивайсиз А/С Pressurised container containing haemostatic paste
RU2636240C2 (en) 2012-06-12 2017-11-21 Ферросан Медикал Дивайсиз А/С Dry haemostatic composition
CN105358071B (en) 2013-06-21 2018-07-31 弗罗桑医疗设备公司 The dry composition of vacuum expansion and syringe for retaining the dry composition
WO2015086028A1 (en) 2013-12-11 2015-06-18 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
US11046818B2 (en) 2014-10-13 2021-06-29 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
CN107206165B (en) 2014-12-24 2020-10-23 弗罗桑医疗设备公司 Syringe for holding and mixing first and second substances
CA2986981A1 (en) 2015-07-03 2017-01-12 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
CN108261560B (en) * 2017-01-03 2020-12-08 张家港唯瀚生物科技有限公司 Degradable absorbable hemostatic material containing modified starch nanoparticles and application thereof
EP3790600B1 (en) 2018-05-09 2023-12-27 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition
CN113144277B (en) * 2021-04-13 2022-06-14 武汉理工大学 Injectable fluid gelatin and preparation method and application thereof
CN114470307B (en) * 2022-04-06 2022-06-24 天新福（北京）医疗器材股份有限公司 Degradable hemostatic plugging adhesive and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2772999A (en) * 1952-06-06 1956-12-04 Johnson & Johnson Hemostatic surgical compositions and dressings
FR1325128A (en) * 1962-03-26 1963-04-26 Process for preparing bioplasts which can be used as resorbable prostheses
US3523807A (en) * 1966-11-25 1970-08-11 Mihaly Gerendas Method of making a cross-linked fibrin prosthesis
US3742955A (en) * 1970-09-29 1973-07-03 Fmc Corp Fibrous collagen derived product having hemostatic and wound binding properties
US4006220A (en) * 1975-06-04 1977-02-01 Gottlieb Sheldon K Compositions and methods useful for repairing depressed cutaneous scars

Also Published As

Publication number Publication date
FR2410477A1 (en) 1979-06-29
GB1584080A (en) 1981-02-04
HU179969B (en) 1983-01-28
IE47606B1 (en) 1984-05-02
IL56110A (en) 1981-09-13
IL56110A0 (en) 1979-03-12
DE2852319C2 (en) 1990-08-16
FR2410477B1 (en) 1981-11-13
IE782393L (en) 1979-06-05
MY8200056A (en) 1982-12-31
DE2852319A1 (en) 1979-06-07
HK34681A (en) 1981-07-24
CA1119515A (en) 1982-03-09

Similar Documents

Publication Publication Date Title
FR2378555B1 (en)
FR2410477B1 (en)
FR2376694B1 (en)
FR2377522B1 (en)
FR2377682B1 (en)
FR2379134B1 (en)
FR2377857B1 (en)
FR2378882B1 (en)
AU3353778A (en)
FR2376755B3 (en)
AR210643A1 (en)
AU495917B2 (en)
AU71461S (en)
BG25855A1 (en)
BE865722A (en)
BG25844A1 (en)
BG25841A1 (en)
BG25840A1 (en)
BG25839A1 (en)
BG25838A1 (en)
BG25837A1 (en)
BG25834A1 (en)
BG25829A1 (en)
BG25828A1 (en)
BG25827A2 (en)